CDMC Event: China Vaccine Focus 2011

Your Gateway to China’s Vaccine Market
With nearly 1.4 bn people and approximately 17 million newborns each year, China has already been the largest producer and user of world vaccine products. Enhancing disease prevention awareness in adults, the spread of influenza A/H1N1 and other infectious diseases and Chinese government’s increased investment in epidemic prevention systems, recent improvements in China’s regulatory, market, and technology scenario are all together creating an optimistic outlook for its vaccine industry. The Chinese vaccine market competition is now transferring from the former price competition model to a technology competition model. Several global vaccine giants such as Sanofi Pasteur, GlaxoSmithKline, Novartis and Merck have already gotten their feet in the door and are awaiting further opportunities to force their way deeper within the China vaccine market.

On the other hand, biotechs are also finding progress in the vaccine market. Vaccine giants are relying on an ecosystem of smaller companies to fill its pipeline with preventive therapies. And that pipeline could grow now that the Bill and Melinda Gates Foundation has pledged $10 billion to fund vaccine research. Vaccine services from CMO/CRO, packaging to equipments will also benefit from the vaccine industry boom.

What do China’s "Twelfth Five-Year Plan" and new GMP regulation ring to domestic and foreign vaccine players? How to align vaccine development strategies with changing business landscape? Centered around the topic of "New GMP: Developing Safe, Reliable, High Yield Vaccines for a Healthier World ", CVF2011 will track various focus points on vaccines for infectious diseases, non-infectious diseases, AIDS vaccines, cancer vaccines, RNA/DNA vaccines, and point to the best opportunities for R&D partnering and manufacturing excellence.

By the present of senior officials from Ministry of Health, PRC, SFDA/ FDA, NICPBP to address the latest regulatory issues on development of China vaccine industry. Through two days’ various sessions such as keynote presentations, interactive panel discussions, case studies, cocktail party and scheduled one-to-one business meetings, you will hear the perspectives of both Chinese and MNC vaccine leaders. They will provide insights into their own company strategies for the coming years and how each perceives the marketplace developments. It will help you to win the vaccine market competition and strengthen your company’s dynamic growth in China’s vaccine market.

Download

CDMC Partnering
Online System